AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

1,026.032

-3.152-0.31%

Number of Gainers:12

Number of Losers:6

Number of Flat:14

PE:- -

High:1,028.492

Open:1,028.011

Low:1,016.051

Close:1,029.184

Loading ...

AnteoTech Appoints Interim CEO

MT Newswires Live

Anteotech Ltd - David Radford Steps Down as CEO

THOMSON REUTERS

Anteotech - Appoints Merrill Gray as Interim CEO and Managing Director

THOMSON REUTERS

CSL, Resmed Are Morgan Stanley's Australia Healthcare Picks in the Tariff Era -- Market Talk

Morgan Stanley’s top-ranked ASX healthcare picks for right now

ASX Small-Cap Stocks to Watch

MT Newswires Live

Is the CSL share price a buy? Here's a top broker's view

How I'd invest in ASX 200 shares if I wanted to sleep well during market volatility

Here are the top 10 ASX 200 shares today

Australian Shares Rise Amidst Temporary Reprieve for Electronic Tariffs; EBR Systems Receives US FDA Approval for Heart Failure Treatment Device

MT Newswires Live

BUZZ-Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs

5 'particularly interesting' ASX All Ords stocks to buy amid the Trump tariff mayhem

How will Ansell shares navigate tariffs according to Macquarie?

Aeris Environmental Insider Ups Holding During Year

Simply Wall St.

Market Chatter: Coles Rejigs Fresh Produce Strategy as Price War Brews with Woolworths

MT Newswires Live

Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.

ResMed Bull Braces for Possible Short-Lived Selloff -- Market Talk

Woolworths Group Limited (ASX:WOW) Delivered A Better ROE Than Its Industry

Simply Wall St.

How to build a $500 per month income stream with ASX dividend shares

What I'd buy if I wanted to turn $10,000 into $100,000 with ASX shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7501/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":1026.0322,"timestamp":1744869599995,"preClose":1029.1838,"halted":0,"volume":27306249,"delay":0,"changeRate":-0.003062,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-3.151611,"latestTime":"04-17 16:00:00 AEST","open":1028.0107,"high":1028.4921,"low":1016.0511,"amount":212098520,"amplitude":0.012088,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1744848000000,1744869600000]],"turnoverRate":0.001941,"increases":11,"decrements":9,"flats":13,"marketCap":258613159044.25,"floatMarketCap":212810070398.33594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":1028.4921,"amplitude":0.012088,"preClose":1029.1838,"low":1016.0511,"latestPrice":1026.0322,"volume":27306249,"delay":0,"open":1028.0107,"prevYearClose":1117.913,"prevWeekClose":1026.032,"prevMonthClose":1021.93,"prevQuarterClose":1021.93,"fiveDayClose":1030.927,"twentyDayClose":1019.069,"sixtyDayClose":1093.998,"secType":"PLATE","market":"AU","turnoverRate":0.001941,"marketCap":258613159044.25,"floatMarketCap":212810070398.33594,"timestamp":1744869599995,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":12,"down":6,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527675431","title":"AnteoTech Appoints Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2527675431","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527675431?lang=en_us&edition=fundamental","pubTime":"2025-04-15 13:42","pubTimestamp":1744695763,"startTime":"0","endTime":"0","summary":"AnteoTech  appointed Merrill Gray as interim Chief Executive Officer and Managing Director, effective April 16, according to a Tuesday filing with the Australian bourse.Gray will succeed David Radord who is stepping down on Tuesday but will continue to serve as strategic advisor for the next four weeks, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADO.AU","XKO.AU","XAO.AU","XJO.AU","BK7501","BK7048","BK7036","BK7508"],"gpt_icon":0},{"id":"2527433231","title":"Anteotech Ltd - David Radford Steps Down as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2527433231","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527433231?lang=en_us&edition=fundamental","pubTime":"2025-04-15 12:55","pubTimestamp":1744692947,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS27B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADO.AU","BK7501","BK7048","BK7036","BK7508"],"gpt_icon":0},{"id":"2527230433","title":"Anteotech - Appoints Merrill Gray as Interim CEO and Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2527230433","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527230433?lang=en_us&edition=fundamental","pubTime":"2025-04-15 12:55","pubTimestamp":1744692947,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS27B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7036","BK7508","BK7501","ADO.AU","BK7048"],"gpt_icon":0},{"id":"2527481820","title":"CSL, Resmed Are Morgan Stanley's Australia Healthcare Picks in the Tariff Era -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2527481820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527481820?lang=en_us&edition=fundamental","pubTime":"2025-04-15 11:51","pubTimestamp":1744689060,"startTime":"0","endTime":"0","summary":"0351 GMT - Biopharmaceutical company CSL and medical equipment firm Resmed have the best combination of attractive valuation and low tariff impact among Australian healthcare stocks, suggests Morgan Stanley equity analyst David L. Bailey. He estimates that CSL would need to raise prices by 1% and Resmed would need to raise prices by 2%-3% to offset the earnings impact from tariffs. But given their solid earnings per share growth, low earnings risk and valuation appeal, he says these companies are the \"most favorably positioned\" among peers. One word of caution--pharmaceuticals are currently excluded from reciprocal tariffs, but Trump has signaled he wants to put tariffs on that sector soon, which could impact CSL. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU0314104364.USD","LU0971096721.USD","LU1720051017.SGD","BK7508","LU2023251221.USD","LU1668664300.SGD","BK4548","RMD","LU1169590202.USD","BK4567","SGXZ23171101.USD","LU1989772840.SGD","LU0795875086.SGD","CSL","LU2347655156.SGD","LU1548497426.USD","LU1363072403.SGD","LU1732800096.USD","BK4137","BK4581","HCSG","LU0795875169.SGD","BK4534","BK4588","LU2271345857.HKD","CSL.AU","BK4127","BK7511","BK7501","LU0225283273.USD","LU2089284900.SGD","LU0158827781.USD","LU0320765646.SGD","BK4516","LU1074936037.SGD","LU0912757837.SGD","RMD.AU","LU1720051108.HKD","LU0170899867.USD","LU2089283258.USD","MS","LU1162221912.USD","LU2177674079.SGD","LU0158827948.USD","LU0728928796.USD","BK4086","BK4082","LU0098860793.USD","SG9999004303.SGD"],"gpt_icon":1},{"id":"2527107074","title":"Morgan Stanley’s top-ranked ASX healthcare picks for right now","url":"https://stock-news.laohu8.com/highlight/detail?id=2527107074","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527107074?lang=en_us&edition=fundamental","pubTime":"2025-04-15 10:46","pubTimestamp":1744685174,"startTime":"0","endTime":"0","summary":"Despite the latest noises out of the White House promising some tariff respite, Trump’s ongoing trade war remains the big spectre looming over markets.According to research from Morgan Stanley, one sector that could weather the storm is healthcare, especially if the worst were to happen and we entered a period of stagflation or even recession.Here are its two big-name stock picks and the reasons it thinks the sector is well-positioned right now.While pharmaceuticals are currently exempt from US tariffs, Trump hinted that an announcement on specific pharma tariffs could be expected “soon”.Regardless, Morgan Stanley believes leading ASX health stocks should be able to offset any tariff impact through minimal price increases.Using the GFC as an instructive case study, Morgan Stanley reviewed the performance of the healthcare industry against the ASX 200during that time in case we entered a similar period of lower growth, higher inflation and more unemployment.According to Morgan Stanley's","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/morgan-stanley-s-top-ranked-asx-healthcare-picks-for-right-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/morgan-stanley-s-top-ranked-asx-healthcare-picks-for-right-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU2347655156.SGD","LU2133065610.SGD","LU1363072403.SGD","LU1989772923.USD","LU0098860793.USD","BK7007","LU2357305700.SGD","MS","LU0006306889.USD","LU0106831901.USD","LU0225283273.USD","LU0795875086.SGD","BK4504","BK7508","LU2271345857.HKD","LU0912757837.SGD","BK7067","IE00BKVL7J92.USD","LU1720051108.HKD","LU0971096721.USD","LU0314104364.USD","BK4581","CSL.AU","RMD.AU","BK4516","BK7501","BK4585","LU0795875169.SGD","LU2028103732.USD","LU0158827948.USD","LU1720051017.SGD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU1732800096.USD","LU2089284900.SGD","LU0106261372.USD","BK7511","LU0158827781.USD","LU1668664300.SGD","BK4588","LU2023251221.USD","LU2111349929.HKD","LU2089283258.USD","LU1989772840.SGD","LU1162221912.USD","LU0320765646.SGD","BK4127","LU1732799900.SGD","LU0267386448.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2527912710","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2527912710","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527912710?lang=en_us&edition=fundamental","pubTime":"2025-04-15 07:42","pubTimestamp":1744674140,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Noxopharm Noxopharm passed its final in vivo preclinical safety study for its SOF-SKN drug candidate for autoimmune diseases, with no issues identified, ahead of regulatory submission for the Heracles clinical trial.Great Western Exploration Great Western Exploration completed its maiden drilling program at the Sumo niobium target, located within its Yerrida North project in Western Australia.Swift Networks Group Swift Networks Group extended the closing date of its entitlement offer by two weeks to May 6, following \"significant\" global stock market volatility and shareholder requests. The extension allows additional time to receive the entitlement offer material and evaluate the opportunity.Rincon Resources Rincon Resources completed a site visit to its Laverton gold project in Western Australia and is now preparing for its first drilling on-ground since 2021.Aurumin Auru","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GTE.AU","BK7501","RCR.AU","BK7035","BK7067","BK7104","BK7508","XKO.AU","AUN.AU","XAO.AU","XJO.AU","SW1.AU","BK7095","NOX.AU"],"gpt_icon":0},{"id":"2527109122","title":"Is the CSL share price a buy? Here's a top broker's view","url":"https://stock-news.laohu8.com/highlight/detail?id=2527109122","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527109122?lang=en_us&edition=fundamental","pubTime":"2025-04-15 06:47","pubTimestamp":1744670841,"startTime":"0","endTime":"0","summary":"The CSL Ltd (ASX: CSL) share price is down 15% since the start of 2025 and 20% in the last six months, as the chart below shows. After a sizeable decline, interested investors may be wondering whether","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/15/is-the-csl-share-price-a-buy-heres-a-top-brokers-view/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1169589451.USD","CSL","BK7508","SG9999004303.SGD","BK7501","BK7067","LU1169590202.USD","BK4086","SGXZ23171101.USD","BK7511","LU0728928796.USD","CSL.AU"],"gpt_icon":0},{"id":"2527713444","title":"How I'd invest in ASX 200 shares if I wanted to sleep well during market volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2527713444","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527713444?lang=en_us&edition=fundamental","pubTime":"2025-04-14 17:33","pubTimestamp":1744623232,"startTime":"0","endTime":"0","summary":"Let's face it — the share market can be a stressful place when prices are falling, headlines are screaming, and your portfolio is flashing red. But the truth is, volatility is part of the investment r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/how-id-invest-in-asx-200-shares-if-i-wanted-to-sleep-well-during-market-volatility/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7082","BK7099","IVV.AU","BK7067","BK4585","COL.AU","TLS.AU","BK4588","BK7510","BK7155","NDQ.AU","BK7501","BK7040","BK7007","QLTY.AU","RMD.AU","GMG.AU","BK7511","BK4550","BK7508","BK7042","CSL.AU","FDN"],"gpt_icon":0},{"id":"2527186297","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2527186297","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527186297?lang=en_us&edition=fundamental","pubTime":"2025-04-14 15:01","pubTimestamp":1744614107,"startTime":"0","endTime":"0","summary":"It was a flying start to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After a rough end to last week, investors came back from the weekend with a spring in their steps. By the ti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/here-are-the-top-10-asx-200-shares-today-14-april-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SMR.AU","BK7067","XJO.AU","BK7504","PME.AU","NEU.AU","PNV.AU","BK7501","BK7129","BK7016","WHC.AU","BK7507","CU6.AU","SDR.AU","BK7083","MSB.AU","BK7096","BK7126","BK7094","BK7062","PNI.AU","BK7095","BK7508","MIN.AU"],"gpt_icon":0},{"id":"2527977273","title":"Australian Shares Rise Amidst Temporary Reprieve for Electronic Tariffs; EBR Systems Receives US FDA Approval for Heart Failure Treatment Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2527977273","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527977273?lang=en_us&edition=fundamental","pubTime":"2025-04-14 14:59","pubTimestamp":1744613994,"startTime":"0","endTime":"0","summary":"Australian shares rose on Monday after US President Trump temporarily exempted China from a 125% tariff on popular electronics and introduced flat 10% tariffs on electronics around the globe.The S&P/A","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK4081","EBR","BK7007","IE00B1B80R65.USD","COL.AU","XJO.AU","BK7040","WOW.AU","NEU.AU","BK7501","BK7511","BK7096","BK7082","XAO.AU","CRT","XKO.AU","EBR.AU","BK4213"],"gpt_icon":0},{"id":"2527978495","title":"BUZZ-Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527978495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527978495?lang=en_us&edition=fundamental","pubTime":"2025-04-14 13:17","pubTimestamp":1744607871,"startTime":"0","endTime":"0","summary":"BUZZ-Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs** Index of Australian Healthcare stocks .AXHJ rises 1.9%, tracking broadly positive market sentiment .A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4N3QS0C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAN.AU","BK7048","BK7126","CSL.AU","PNV.AU","BK7511","BK7508","BK7501","TRJ.AU","NEU.AU","ARX.AU","BK7503","BK7067","BK7096"],"gpt_icon":0},{"id":"2527511133","title":"5 'particularly interesting' ASX All Ords stocks to buy amid the Trump tariff mayhem","url":"https://stock-news.laohu8.com/highlight/detail?id=2527511133","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527511133?lang=en_us&edition=fundamental","pubTime":"2025-04-14 13:12","pubTimestamp":1744607549,"startTime":"0","endTime":"0","summary":"The All Ordinaries Index  is up a welcome 1.38% on Monday, but most ASX All Ords stocks remain well down from the market highs on 14 February. Indeed, the All Ords is still down 9.78% since notching its record closing high on the day. The headwinds that have dragged on global and Aussie stock markets alike since then can largely be pinned on the unpredictable and oft-changing trade policies under United States President Donald Trump. Trump's sweeping global tariffs, in particular, have unsettled investors. This, in turn, sent many ASX All Ords stocks tumbling despite no likely fundamental changes to their long-term prospects. \"We, like almost every other investor on the planet, underestimated Trump's resolve to reshape global trade and just how far he appears willing to go to do this,\" said Jun Bei Liu, founder and lead portfolio manager at Ten Cap . Liu pointed to Trump's 2 April 'Liberation Day' tariff announcement as having \"drastically changed the course of the macroeconomic and in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/5-particularly-interesting-asx-all-ords-stocks-to-buy-amid-the-trump-tariff-mayhem/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","BK7016","FPH.AU","XAO.AU","BK7002","BK7501","REA.AU","BK7503","BK7007","COH.AU","PME.AU","360.AU"],"gpt_icon":0},{"id":"2527392706","title":"How will Ansell shares navigate tariffs according to Macquarie?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527392706","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527392706?lang=en_us&edition=fundamental","pubTime":"2025-04-14 12:31","pubTimestamp":1744605081,"startTime":"0","endTime":"0","summary":"Ansell Ltd  shares have been under pressure since the US announced reciprocal tariffs on goods from several countries around two weeks ago.  Shares in the protective personal equipment  company are down 13% for the year and currently trade at $29.27 apiece, having slipped from $34.43 on April 1st. Now, Macquarie analysts have weighed in on the potential impact of these tariffs on Ansell and its local shareholders. Here's what the bank says investors need to know.  How might tariffs impact Ansell shares?Macquarie also revised its target price for Ansell shares, lowering it by more than 20% from $40.30 to $31.05.  This reflects the expected impact of tariffs on earnings and the broader uncertainty in the industrial sector. The broker has also downgraded Ansell from a buy to a hold rating.  Macquarie also revised its forecasts on Ansell, now proje","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/how-will-ansell-shares-navigate-tariffs-according-to-macquarie/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7126","MQG.AU","BK7501","BK7046","BK7511","ANN.AU","BK7057","PPE.AU"],"gpt_icon":0},{"id":"2527926268","title":"Aeris Environmental Insider Ups Holding During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2527926268","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527926268?lang=en_us&edition=fundamental","pubTime":"2025-04-14 11:19","pubTimestamp":1744600787,"startTime":"0","endTime":"0","summary":"Viewing insider transactions for Aeris Environmental Ltd's  over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.  Our free stock report includes 5 warning signs investors should be aware of before investing in Aeris Environmental.Aeris Environmental Insider Transactions Over The Last Year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aeris-environmental-insider-ups-holding-031947974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["AEI.AU","BK7501","BK7047"],"gpt_icon":0},{"id":"2527941020","title":"Market Chatter: Coles Rejigs Fresh Produce Strategy as Price War Brews with Woolworths","url":"https://stock-news.laohu8.com/highlight/detail?id=2527941020","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527941020?lang=en_us&edition=fundamental","pubTime":"2025-04-14 10:17","pubTimestamp":1744597047,"startTime":"0","endTime":"0","summary":"Coles Group  is planning to restructure its all-important fresh produce section in a move that could renew a price war with supermarket rival Woolworths Group , The Australian reported on April 13, citing a Coles executive.Coles will transition to a 12-week promotion planning cycle, significantly longer than the current 10-day cycle, Charlotte Gilbert, Coles general manager for fresh produce, told The Australian.Gilbert said this will enable the company to think longer-term and improve relationships with suppliers and customers through better promotional allocations. In comparison, the current cycle  \"often leads to volatility\" and \"embeds a reactive culture,\" Gilbert added.The move is expected to challenge Woolworths at a time when shoppers bemoan elevated grocery prices. In February, Woolworths disclosed AU$400 million in savings, which are expected to be partly allocated to discounts and promos, The Australian said.Woolworths did not immediately respond to MT Newswires' request for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4516","COL.AU","BK4588","XAO.AU","BK7511","BK4595","BK7082","XKO.AU","STRK","WOW.AU","BK4585","BK4596","BK7501","XJO.AU","BK4600","BK4023","BK7040"],"gpt_icon":1},{"id":"2527140929","title":"Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527140929","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527140929?lang=en_us&edition=fundamental","pubTime":"2025-04-14 07:49","pubTimestamp":1744588166,"startTime":"0","endTime":"0","summary":"CSL  has had a rough three months with its share price down 17%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Particularly, we will be paying attention to CSL's  ROE today.Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital.The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. What is CSL worth today?The  intrinsic value infographic in our free research report  helps visualize whether CSL is currently mispriced by the market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/csl-limiteds-asx-csl-fundamentals-234926416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["SG9999004303.SGD","BK7511","BK7501","BK7508","BK7067","LU1169590202.USD","SGXZ23171101.USD","CSL.AU","CSL","LU0728928796.USD","BK4086","LU1169589451.USD"],"gpt_icon":0},{"id":"2527382915","title":"ResMed Bull Braces for Possible Short-Lived Selloff -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2527382915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527382915?lang=en_us&edition=fundamental","pubTime":"2025-04-14 07:21","pubTimestamp":1744586460,"startTime":"0","endTime":"0","summary":"2321 GMT -- ResMed's bull at Citi is bracing for the possibility of a short-lived share sell-off when trial results from Eli Lilly's Orforglipron weight-loss drug are announced. Analyst Mathieu Chevrier keeps a buy rating on the breathing-tech provider, but opens a 90-day downside catalyst watch on the release of Orforglipron's phase 3 readout, which is expected some time in the June quarter. Chevrier reminds clients in a note that ResMed's share price has reacted negatively to GLP-1 news in the past, but he doesn't expect any selloff to be long-lasting. Citi has a A$44.00 target price on the stock, which is at A$34.21 ahead of the open. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU2008162690.USD","LU2177674079.SGD","RMD.AU","BK7007","RMD","BK4082","BK4588","BK4567","BK7501","BK4548","BK4504","BK4585"],"gpt_icon":1},{"id":"2527391118","title":"Woolworths Group Limited (ASX:WOW) Delivered A Better ROE Than Its Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2527391118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527391118?lang=en_us&edition=fundamental","pubTime":"2025-04-14 06:35","pubTimestamp":1744583725,"startTime":"0","endTime":"0","summary":"While some investors are already well versed in financial metrics , this article is for those who would like to learn about Return On Equity  and why it is important. We'll use ROE to examine Woolworths Group Limited , by way of a worked example.Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.Combining Woolworths Group's Debt And Its 31% Return On Equity","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/woolworths-group-limited-asx-wow-223525995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7501","BK7511","ROE","WOW.AU","BK7040","BK4100","WOW"],"gpt_icon":0},{"id":"2527892852","title":"How to build a $500 per month income stream with ASX dividend shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2527892852","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527892852?lang=en_us&edition=fundamental","pubTime":"2025-04-14 06:15","pubTimestamp":1744582500,"startTime":"0","endTime":"0","summary":"If you're still in the accumulation phase, reinvesting your dividends through dividend reinvestment plans  can supercharge your long-term returns. But if you're ready to withdraw income, it could be worth constructing your holdings so you receive payments regularly throughout the year. Some investors even structure their portfolio by payout months, blending stocks that pay in different quarters to smooth out their income. Foolish takeaway $500 a month in passive income isn't out of reach — it is a matter of consistency, quality stock selection, and giving your investments time to do the heavy lifting. And with dividend yields from some ASX shares sitting well above savings account rates, the passive income potential is as attractive as it has been in years. It might not happen overnight, but if you start today, that $500 per mon","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/how-to-build-a-500-per-month-income-stream-with-asx-dividend-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7005","BK7162","COL.AU","GQG.AU","BK7040","BK7042","BK7511","BK7082","BK7501","BK7062","TLS.AU","HDN.AU"],"gpt_icon":0},{"id":"2527329935","title":"What I'd buy if I wanted to turn $10,000 into $100,000 with ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2527329935","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527329935?lang=en_us&edition=fundamental","pubTime":"2025-04-13 06:06","pubTimestamp":1744495560,"startTime":"0","endTime":"0","summary":"You'll probably be waiting a long time. The better approach is to start with what you have, invest in quality, and stay consistent. This is where dollar cost averaging can help — buying regularly smooths out volatility and removes the guesswork. The real secret isn't predicting the next breakout winner — it is being early, being patient, and staying disciplined. What would I buy?Personally, I'd be looking for long-term compounders with real staying power. Businesses like ResMed Inc , WiseTech Global Ltd , and Xero Ltd , or an ETF like BetaShares Nasdaq 100 ETF  or VanEck Morningstar Wide Moat ETF  — names that don't just grow, but compound earnings over time. They won't all shoot the lights out overnight. But give them a decade or more, and they could do some serious heavy lifting. Foolish takeaway Growing $10,000 into $100,000 isn't about luck. It is about owning great businesses, staying invested, and letting time do what time does best. It might take years. It will definitely","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/13/what-id-buy-if-i-wanted-to-turn-10000-into-100000-with-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7016","NDQ.AU","RMD.AU","BK7007","WTC.AU","BK7503","BK4585","MOAT.AU","XRO.AU","BK7501","BK4588","BK4550","FDN"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":107,"code":"91000000","status":"200"}]}}